Diabetes in association with other endocrine disorders.

[1]  P. Gorden,et al.  Efficacy of conventional pituitary irradiation in acromegaly. , 1970, The New England journal of medicine.

[2]  V. McKusick,et al.  Diabetes mellitus and sexual ateliotic dwarfism: a comparative study. , 1970, The Journal of clinical investigation.

[3]  W. A. Müller,et al.  Studies of pancreatic alpha cell function in normal and diabetic subjects. , 1970, The Journal of clinical investigation.

[4]  S. Fineberg,et al.  Insulin secretion in acromegaly. , 1970, The Journal of clinical endocrinology and metabolism.

[5]  G. Spergel,et al.  Studies on the carbohydrate and lipid metabolism in thyroid disease: effects of glucagon. , 1970, The Journal of clinical endocrinology and metabolism.

[6]  C. Lowy,et al.  Serum-insulin in acromegaly. , 1969, Lancet.

[7]  V. Wynn,et al.  Effects of Oral and Intravenous Glucose Loading in Thyrotoxicosis: Studies of Plasma Glucose, Free Fatty Acid, Plasma Insulin and Blood Pyruvate Levels , 1969, Diabetes.

[8]  D. Porte,et al.  Insulin and glucagon responses in subjects with pheochromocytoma: effect of alpha adrenergic blockade. , 1969, The Journal of clinical endocrinology and metabolism.

[9]  V. McKusick,et al.  Isolated human growth hormone deficiency. III. Insulin secretion in sexual ateliotic dwarfism , 1968 .

[10]  R. Unger,et al.  Studies of muscle capillary basement membranes in normal subjects, diabetic, and prediabetic patients. , 1968, The Journal of clinical investigation.

[11]  N. Ertel,et al.  Carbohydrate and fat metabolism in patients with pheochromocytoma. , 1968, The New England journal of medicine.

[12]  C. Kilo,et al.  A glucagon-secreting alpha-cell carcinoma of the pancreas. , 1966, The New England journal of medicine.

[13]  D. Kipnis,et al.  Effect of glucocorticoids on plasma insulin. , 1966, The New England journal of medicine.

[14]  L. Braverman,et al.  Reversal by guanethidine of abnormal oral glucose tolerance in thyrotoxicosis. , 1966, Lancet.

[15]  A. Lawrence.  Radioimmunoassayable glucagon levels in man: effects of starvation, hypoglycemia, and glucose administration. , 1966, Proceedings of the National Academy of Sciences of the United States of America.

[16]  B. Wajchenberg,et al.  Carbohydrate Metabolism in Hyperadrenocorticism , 1966, Diabetes.

[17]  H. Knowles,et al.  Observations in Hyperthyroidism of Abnormal Glucose Tolerance and Other Traits Related to Diabetes Mellitus , 1965, Diabetes.

[18]  R. Salama.  THE SHAPE OF MOLECULES TO COME. , 1965, Lancet.

[19]  J. Ashmore.  HORMONAL MODIFIERS OF INSULIN ACTION. NEW YORK DIABETES ASSOCIATION SYMPOSIUM. II. THE EFFECTS OF GLUCOCORTICOIDS ON INSULIN ACTION. , 1964, Diabetes.

[20]  R. Levine.  Analysis of the Actions of the Hormonal Antagonists of Insulin , 1964, Diabetes.

[21]  E. Newsholme,et al.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. , 1963, Lancet.

[22]  H. Elrick,et al.  Influence of thyroid function on carbohydrate metabolism and a new method for assessing response to insulin. , 1961, The Journal of clinical endocrinology and metabolism.

[23]  L. Kyle,et al.  Myxedema; a reevaluation of clinical diagnosis based on eighty cases. , 1959, A.M.A. archives of internal medicine.

[24]  J. Bunker,et al.  The pattern of intermediary carbohydrate metabolism in Cushing's syndrome. , 1957, The American journal of medicine.

[25]  S. Ellis.  The metabolic effects of epinephrine and related amines. , 1956, Pharmacological reviews.

[26]  V. Dole.  A relation between non-esterified fatty acids in plasma and the metabolism of glucose. , 1956, The Journal of clinical investigation.

[27]  D. Baron.  Hypothyroidism and diabetes mellitus. , 1955, Lancet.

[28]  N. Elgee,et al.  Effects of thyroid function on insulin-I131 degradation. , 1954, The American journal of physiology.

[29]  C. Plotz,et al.  The natural history of Cushing's syndrome. , 1952, The American journal of medicine.

[30]  M. Goldner,et al.  Pheochromocytoma with diabetes; a case report and discussion. , 1947, The Journal of clinical endocrinology and metabolism.

[31]  D. Porte.  A receptor mechanism for the inhibition of insulin release by epinephrine in man. , 1967, The Journal of clinical investigation.